Primary and recurrent infections of human cytomegalovirus (HCMV) can occur during pregnancy. Both can result in congenital infection, the leading infectious cause of mental retardation, sensorineural deafness and visual impairment. The intrauterine transmission of HCMV and an adverse outcome are mainly related to a primary maternal infection. However, there is currently increasing evidence that the incidence of symptomatic infections in infants born to immune mothers is higher than previously thought. The option of a prenatal diagnosis therefore has a crucial role in the management of pregnancies complicated by active HCMV infection. In spite of the potentially devastating consequences of congenital HCMV infection, little information is available concerning antiviral therapy as prophylactic treatment for women at high risk of the transmission of HCMV during pregnancy. Passive immunization for the prevention of vertical transmission of the virus appears promising. Until a HCMV vaccine is available, education is needed regarding the risk involved and the strategies to be adopted for the prevention of HCMV infection during pregnancy.
[1]. E. S. Mocarski Jr. T. Shenk R. F. Pass 2007 Cytomegaloviruses D. M. Knipe P. M. Howley D. E. Griffin Fields Virology 5th edition Lippincott Williams and Wilkins Philadelphia 2701–2772.
[2]. S. Stagno W. Britt 2006 Cytomegalovirus infections J. S. Remington J. O. Klein C. B. Wilson C. J. Baker Infectious Diseases of the Fetus and Newborn Infant 6th edition Elsevier Saunders Philadelphia 739–781.
[3]. S. A. S. Staras S. C. Dollard K.W. Radford 2006 Seroprevalence of cytomegalovirus infection in the United States, 1988–1994 Clin. Infect. Dis. 43 1143–1151.
[4]. E. Pethő J. Geiger 1996 Seroprevalence of cytomegalovirus, Epstein-Barr virus and toxoplasma in the normal population Transzfúzió 29 3–7.
[5]. R. Pusztai J. Deák A. Kátai 2003 Strain-specific humoral immunity to human cytomegalovirus in pregnant women Bull. Med. Sci. 76 124–127.
[6]. C. T. Leach R. Detels K. Hennessey 1994 A longitudinal study of cytomegalovirus infection in human immunodeficiency virus type 1-seropositive homosexual men: Molecular epidemiology and association with disease progression J. Infect. Dis. 170 293–298.
[7]. S. H. Chandler H. H. Handsfield J. K. McDougall 1987 Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted diseases J. Infect. Dis. 155 655–660.
[8]. J. F. Bale S. J. Petheram E. S. Inara 1996 Cytomegalovirus reinfection in young children J. Pediatr. 128 347–352.
[9]. A. S. Istas G. J. Demmler 1995 Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry Clin. Infect. Dis. 20 665–670.
[10]. S. P. Adler 1992 Cytomegalovirus and pregnancy Curr. Opin. Obstet. Gynecol. 4 670–675.
[11]. S. Stagno G. A. Cloud 1994 Working parents: the impact of day care and breast-feeding on cytomegalovirus infections in offspring Proc. Natl. Acad. Sci. USA 91 2384–2389.
[12]. C. Hutto A. Little R. Ricks 1986 Isolation of cytomegalovirus from toys and hands in day care center J. Infect. Dis. 154 527–53.
[13]. S. P. Adler 1989 Cytomegalovirus and child day care: evidence for an increased infection rate among day-care workers N. Engl. J. Med. 321 1290–1296.
[14]. S. Chou 1990 Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens J. Infect. Dis. 162 738–742.
[15]. S. B. Boppana L. B. Rivera K. B. Fowler 2001 Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity N. Engl. J. Med. 344 1366–1371.
[16]. M. G. Revello M. Zavattoni M. Furione 2002 Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infection J. Infect. Dis. 186 553–557.
[17]. M. G. Revello M. Zavattoni M. Furione 2006 Preconceptional primary human cytomegalovirus infection and risk of congenital infection J. Infect. Dis. 193 783–787.
[18]. M. G. Revello G. Gerna 2004 Pathogenesis and prenatal diagnosis of human cytomegalovirus infection J. Clin. Virol. 29 71–83.
[19]. S. Stagno R. F. Pass G. Cloud 1986 Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome JAMA 256 1904–1908.
[20]. M. D. Yow D.W. Williamson L. J. Leeds 1988 Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants Am. J. Obstet. Gynaecol. 58 1189–1195.
[21]. K. B. Fowler S. Stagno R. F. Pass 1992 The outcome of congenital cytomegalovirus infection in relation to maternal antibody status N. Engl. J. Med. 326 663–667.
[22]. G. Nigro S. P. Adler R. La Torre 2005 Passive immunization during pregnancy for congenital cytomegalovirus infection N. Engl. J. Med. 353 1350–1362.
[23]. T. Lazzarotto P. Spezzacatena S. Varani 1999 Anticytomegalovirus (anti-CMV) immunoglobulon G avidity in identification of pregnant women at risk of transmitting congenital CMV infection Clin. Diagn. Lab. Immunol. 6 127–129.
[24]. C. Sinzger H. Müntefering T. Löning 1993 Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining Virchows Arch. A Pathol. Anat. Histopathol. 423 249–256.
[25]. S. Fisher O. Genbacev E. Maidji 2000 Human cytomegalovirus infection of placenta cytotrophoblast in vitro and in utero: implication for transmission and pathogenesis J. Virol. 74 6808–6820.
[26]. M. Ohyama Y. Motegi A. Goto 1992 Ascending placentofetal infection caused by cytomegalovirus Br. J. Obstet. Gyneacol. 99 770.
[27]. G. Halwachs-Baumann 2006 The congenital cytomegalovirus infection: virus-host interaction for defense and transmission Curr. Pharm. Biotechnol. 7 303–312.
[28]. Gy. Korányi J. Krausz 1980 Congenital cytomegalovirus disease Orv. Hetil. 121 1129–1134.
[29]. T. J. Conboy R. F. Pass S. Stagno 1987 Early clinical manifestations and intellectual outcome in children with symptomatic congenital cytomegalovirus infection J. Pediatr. 111 343–348.
[30]. S. B. Boppana R. F. Pass W. J. Britt 1992 Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality Pediatr. Infect. Dis. J. 11 93–99.
[31]. T. G. Wreghitt E. L. Teare O. Sule 2003 Cytomegalovirus infection in immunocompetent patients Clin. Infect. Dis. 37 1603–1606.
[32]. K. B. Fowler S. Stagno R. F. Pass 1992 The outcome of congenital cytomegalovirus infection in relation to maternal antibody status N. Engl. J. Med. 326 663–667.
[33]. S. B. Boppana K. B. Fowler W. J. Britt 1999 Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus Pediatrics 104 55–60.
[34]. C. Arpino G. C. Gattinara M. Rosso 2008 Cortical maldevelopment in congenital cytomegalovirus infection transmitted by a woman with preexisting immunity J. Neurovirol. 14 173–176.
[35]. Y. Zalel Y. Gilboa M. Berkenshtat 2008 Secondary cytomegalovirus infection can cause severe fetal sequelae despite maternal preconceptional immunity Ultrasound Obstet. Gynecol. 31 417–420.
[36]. T. Lazzarotto B. Guerra M. Lanari 2008 New advances in the diagnosis of congenital cytomegalovirus infection J. Clin. Virol. 41 192–197.
[37]. M. G. Revello G. Gerna 2002 Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant Clin. Microbiol. Rev. 15 680–715.
[38]. K. B. Fowler S. Stagno R. F. Pass 2003 Maternal immunity and prevention of congenital cytomegalovirus infection JAMA 289 1008–1011.
[39]. M. J. Cannon K. F. Davis 2005 Washing our hands of the congenital cytomegalovirus disease epidemic BMC Public Health 5 70.
[40]. S. P. Adler J.W. Finney A. N. Manganello 2004 Prevention of child-to-mother transmission of cytomegalovirus among pregnant women J. Pediatr. 145 485–491.
[41]. D. S. Ross S. C. Dollard M. Victor 2006 The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup J. Women's Health (Larchmt) 15 224–229.
[42]. L. Grangeot-Keros B. Simon F. Audibert 1998 Should we routinely screen for cytomegalovirus antibody during pregnancy? Intervirology 41 158–162.
[43]. C. Peckham P. Tookey S. Logan 2001 Screening options for prevention of congenital cytomegalovirus infection J. Med. Screen. 8 119–124.
[44]. A. Ornoy 2007 Fetal effects of primary and non-primary cytomegalovirus infection in pregnancy: Are we close to prevention? Isr. Med. Assoc. J. 9 398–401.
[45]. R. C. Brandy M. R. Schleiss D. P. Whitte 2002 Placental transfer of ganciclovir in a woman with acquired immunodeficiency syndrome and cytomegalovirus disease Pediatr. Infect. Dis. J. 21 796–797.
[46]. D. P. Puliyanda N. S. Silverman D. Lehman 2005 Successful use of oral ganciclovir for treatment of intrauterine cytomegalovirus infection in a renal allograft recipient Transpl. Infect. Dis. 7 71–74.
[47]. M. G. Michaels 2007 Treatment of congenital cytomegalovirus: where are we now? Expert Rev. Anti Infect. Ther. 5 441–448.
[48]. K. J. Moise H. Wolfe 2008 Treatment of second trimester cytomegalovirus infection with maternal hyperimmune globulin Prenat. Diagn. 28 264–265.
[49]. J. Zhong R. Khanna 2007 Vaccine strategies against human cytomegalovirus infection Expert. Rev. Anti Infect. Ther. 5 449–459.
[50]. M. R. Schleiss 2007 Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection J. Pediatr. 151 564–570.